We introduced the new mould generation

YpsoStory

In week 13 of this year, mould making history was made at Ypsomed. The latest generation of injection moulds was successfully put into operation at the technical centre in Burgdorf. The injection mould in question was the Telescopic Look Sleeve, which was designed and built in-house for the first time as a 16-cavity mould. The special feature here is that the mould produces 32 moulded parts in a single injection cycle and assembles the two parts which belong together while still in the mould – and thus allows 16 assembled parts to be removed from the mould with a pick and place gripper.

Topics:
Innovation & Digital Health

Roman Hovorka, Director CamDiab Ltd with David Bosshard, Vice President Product Management Diabetes Care Ypsomed

YpsoStory

Over 4100 people attended this year’s physical edition of the ATTD – the world of diabetes innovations. With our vision in mind, making self-care simpler and easier, we participated in the event again. We had lively discussions with the numerous visitors about our mylife Loop Program.

Topics:
Innovation & Digital Health

YpsoStory

Ypsomed continuously expands its solution portfolio to include digital services that support patients in their self-medication and their therapy. With our solutions, we help to improve adherence to treatment as well as quality of life and also relieve the burden on the healthcare system.

Topics:
Innovation & Digital Health

Digitisation in diabetes therapy management

Changing patient-doctor relationship

YpsoStory

Digitisation opens the door for new products and new possibilities in the diabetes therapy management. Due to digitisation, patients are gaining knowledge and independence and therefore their demands increase. As a result, the patient-doctor relationship is undergoing change.

Topics:
Innovation & Digital Health

Individualisation in diabetes therapy

YpsoStory

The number of Type 1 diabetics using old insulin pumps without secure communication interfaces to build their own “Closed Loop” system is growing steadily. The so-called “loopers” are thus sending a clear signal to manufacturers and showing what is in demand for insulin pump therapy.

Topics:
Innovation & Digital Health